L. Serrano

发表

Extended-spectrum β-lactamase-producing Enterobacteriaceae from animal origin and wastewater in Tunisia: first detection of O25b-B23-CTX-M-27-ST131 Escherichia coli and CTX-M-15/OXA-204-producing Citrobacter freundii from wastewater.

A. Hassen, L. López-Cerero, Á. Pascual, 2019, Journal of global antimicrobial resistance.

Activity of cefiderocol against high-risk clones of multidrug-resistant Enterobacterales, Acinetobacter baumannii, Pseudomonas aeruginosa and Stenotrophomonas maltophilia

F. Fernández-Cuenca, Á. Pascual, L. Serrano, 2020, The Journal of antimicrobial chemotherapy.

Increased raw poultry meat colonization by extended spectrum beta-lactamase-producing Escherichia coli in the south of Spain.

J. Rodríguez-Baño, L. López-Cerero, Á. Pascual, 2012, International journal of food microbiology.

Within-lineage variability of ST131 Escherichia coli isolates from humans and companion animals in the south of Europe.

J. Rodríguez-Baño, L. López-Cerero, Á. Pascual, 2014, The Journal of antimicrobial chemotherapy.

Virulence Profiles of Bacteremic Extended-Spectrum β-Lactamase-Producing Escherichia coli: Association with Epidemiological and Clinical Features

J. Rodríguez-Baño, L. López-Cerero, Á. Pascual, 2012, PloS one.

Outcome of bacteraemia due to extended-spectrum β-lactamase-producing Escherichia coli: impact of microbiological determinants.

J. Rodríguez-Baño, L. López-Cerero, Á. Pascual, 2013, The Journal of infection.

Outcome of bacteraemia due to extended-spectrum b-lactamase-producing Escherichia coli: Impact of microbiological

Á. Pascual, L. Serrano, N. Fern, 2013 .

Virulence Profiles of Bacteremic Extended-spectrum B- Lactamase-producing Escherichia Coli: Association with Epidemiological and Clinical Features Rodríguez-bañ O Has Been a Consultant for Wyeth, Merck, and Pfizer, Has Served as Speaker for Wyeth, Merck, Pfizer, Astra-zeneca and Glaxosmithkline, and

J. Rodríguez-Baño, L. López-Cerero, Á. Pascual, 2022 .

Escherichia coli O25b:H4/ST131 are prevalent in Spain and are often not associated with ESBL or quinolone resistance.

J. Rodríguez-Baño, L. López-Cerero, J. Cisneros, 2013, Enfermedades infecciosas y microbiologia clinica.

Characterisation of clinical and food animal Escherichia coli isolates producing CTX-M-15 extended-spectrum β-lactamase belonging to ST410 phylogroup A.

D. Paterson, J. Blanco, J. Rodríguez-Baño, 2011, International journal of antimicrobial agents.

Duration of Colonization by Extended-Spectrum β-Lactamase-Producing Enterobacteriaceae in Healthy Newborns and Associated Risk Factors: A Prospective Cohort Study

J. Rodríguez-Baño, L. López-Cerero, Á. Pascual, 2018, Open forum infectious diseases.

Isolation of multidrug-resistant Klebsiella oxytoca carrying blaIMP-8, associated with OXY hyperproduction, in the intensive care unit of a community hospital in Spain.

J. Rodríguez-Baño, L. López-Cerero, Á. Pascual, 2010, The Journal of antimicrobial chemotherapy.

Insertion sequence IS 18 mediates overexpression of bla OXA-257 in a carbapenem-resistant Acinetobacter bereziniae isolate

Á. Pascual, N. Couto, A. Belas, 2013 .

Vagino-rectal colonization and maternal-neonatal transmission of Enterobacteriaceae producing extended-spectrum β-lactamases or carbapenemases: a cross-sectional study.

J. Rodríguez-Baño, L. López-Cerero, Á. Pascual, 2019, Journal of Hospital Infection.

Bacteraemia due to non-ESBL-producing Escherichia coli O25b:H4 sequence type 131: insights into risk factors, clinical features and outcomes.

J. Rodríguez-Baño, L. López-Cerero, Á. Pascual, 2017, International journal of antimicrobial agents.

Incidence and Risk Factors for Acquisition of Extended-Spectrum β-Lactamase-Producing Enterobacteriaceae in Newborns in Seville, Spain: A Prospective Cohort Study.

J. Rodríguez-Baño, L. López-Cerero, Á. Pascual, 2018, International journal of antimicrobial agents.

Within-lineage variability of ST131 Escherichia coli isolates from humans and companion animals in the south of Europe.

J. Rodríguez-Baño, C. Pomba, N. Couto, 2014, The Journal of antimicrobial chemotherapy.